Equatic, a pioneer in combined carbon dioxide removal (CDR) and green hydrogen production, has closed a $11.6 million Series A funding round. The raise was co-led by Catalytic Capital for Climate and Health (C3H), a Temasek Trust initiative, and Kibo Invest, a Singapore-based private investment office focused on climate technology. A consortium of global investors also participated.
The funding will accelerate engineering, commercialization, and manufacturing of Equatic’s patented seawater electrolysis technology, designed to capture atmospheric CO₂ and produce green hydrogen in a single scalable process. Key priorities include advancing Equatic’s first 100-kilotonne commercial CDR facility and expanding its global footprint.
“This investment marks a pivotal moment for Equatic, enabling us to scale production and deliver durable carbon removal at scale,” said Gaurav N. Sant, Founder and CTO of Equatic.
Equatic’s process simultaneously addresses two critical climate challenges—carbon removal and clean energy—offering advantages in cost efficiency and scalability. Lord John Browne, Chairman of Equatic’s Advisory Board, described the technology as “a unique solution with transformative potential.”
Since launching in 2023, Equatic has operated pilot plants in Los Angeles and Singapore, with a demonstration site (Equatic-1) underway in Singapore and a commercial-scale plant planned for Canada. The company has secured recognition from the U.S. Department of Energy, The Earthshot Prize, and major carbon removal registries, and counts Boeing among its carbon credit buyers.
By integrating permanent CDR with green hydrogen production, Equatic positions itself at the intersection of two growing global markets, backed by investors committed to scalable, science-driven climate solutions.
